1. Home
  2. MCHB vs IMNM Comparison

MCHB vs IMNM Comparison

Compare MCHB & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCHB

Mechanics Bancorp

HOLD

Current Price

$14.51

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.06

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHB
IMNM
Founded
1905
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MCHB
IMNM
Price
$14.51
$23.06
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$15.75
$32.80
AVG Volume (30 Days)
450.3K
839.6K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
5.53%
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
N/A
$6,941,000.00
Revenue This Year
$43.32
N/A
Revenue Next Year
N/A
$1,127.34
P/E Ratio
$12.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.82
$7.15
52 Week High
$16.02
$27.65

Technical Indicators

Market Signals
Indicator
MCHB
IMNM
Relative Strength Index (RSI) 40.31 52.81
Support Level $13.89 $19.23
Resistance Level $15.69 $25.10
Average True Range (ATR) 0.48 0.98
MACD -0.13 -0.10
Stochastic Oscillator 37.28 33.94

Price Performance

Historical Comparison
MCHB
IMNM

About MCHB Mechanics Bancorp

Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. its retail banking products include personal checking, savings, and loan products (including credit card, home equity, home mortgage, and secured/unsecured loans), online banking, and wealth management services (including trust and estate, investment management, and financial planning services). its banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing, and loans guaranteed by the Small Business Administration.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: